| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Zahra Bazrafshan, Parsa Mohammadi, Alireza Hasanzadeh, Mohammad Sanjari Moghaddam, Maryam Kabiri, Hossein Sanjari Moghaddam, Amir Hossein Abdolghaffari, Mohammad-Reza Mohammadi, Shahin Akhondzade. Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial. Journal of psychopharmacology (Oxford, England). 2024-12-15. PMID:39676223. |
this study aimed to assess the efficacy and safety of metformin as an adjuvant therapy with risperidone for managing irritability in children diagnosed with autism spectrum disorder (asd). |
2024-12-15 |
2024-12-21 |
Not clear |
| Maiara de Aguiar da Costa, Gustavo Zanette Fernandes, Eduarda Maiochi, Maria Fernanda Pedro Ebs, Flávia da Silva Darós, Sofia Januário Bolan, Rosiane Ronchi Nascimento Costa, Victória Linden de Rezende, Gláucia Crispim da Silva, Rafael Mariano Bitencourt, Cinara Ludvig Gonçalve. Effects of Cannabidiol Isolated or in Association With Risperidone in an Animal Model of Autism. Developmental neurobiology. vol 85. issue 1. 2024-11-28. PMID:39604124. |
effects of cannabidiol isolated or in association with risperidone in an animal model of autism. |
2024-11-28 |
2024-11-30 |
rat |
| Eman A E Farrag, Mona H Askar, Zienab Abdallah, Safinaz M Mahmoud, Eman A Abdulhai, Eman Abdelrazik, Eman Mohamad El Nashar, Faten Mohammed Alasiri, Asma Nasser Saeed Alqahtani, Mamdouh Eldesoqui, Ali M Eldib, Alshimaa Magd. Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism. Behavioral and brain functions : BBF. vol 20. issue 1. 2024-10-01. PMID:39350139. |
comparative effect of atorvastatin and risperidone on modulation of tlr4/nf-κb/nox-2 in a rat model of valproic acid-induced autism. |
2024-10-01 |
2024-10-03 |
rat |
| Eman A E Farrag, Mona H Askar, Zienab Abdallah, Safinaz M Mahmoud, Eman A Abdulhai, Eman Abdelrazik, Eman Mohamad El Nashar, Faten Mohammed Alasiri, Asma Nasser Saeed Alqahtani, Mamdouh Eldesoqui, Ali M Eldib, Alshimaa Magd. Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism. Behavioral and brain functions : BBF. vol 20. issue 1. 2024-10-01. PMID:39350139. |
the present study aimed to investigate the therapeutic effects of atorvastatin in autism and compare it with an approved autism drug (risperidone) through the impact of these drugs on tlr4/nf-κb/nox-2 and the apoptotic pathway in a valproic acid (vpa) induced rat model of autism. |
2024-10-01 |
2024-10-03 |
rat |
| Dhouha Sahnoun, Ahlem Ghanmi, Soumaya Gazzeh, Bochra Saguem, Raoudha Slim, Jaafar Nakhli, Chaker Ben Sale. Risperidone-Induced Leukoneutropenia: Evidence from a Positive Rechallenge and Review of the Literature. Pharmacopsychiatry. vol 57. issue 2. 2024-03-12. PMID:38471512. |
risperidone, less commonly associated with hematologic adverse effects, is an atypical antipsychotic medication used to treat conditions such as schizophrenia, bipolar disorder and irritability associated with autism. |
2024-03-12 |
2024-03-15 |
Not clear |
| Sireen Abdul Rahim Shilbayeh, Iman Sharaf Adeen, Ayman Shawqi Alhazmi, Haya Aljurayb, Rana Saad Altokhais, Nourah Alhowaish, Khawlah Essa Aldilaijan, Mostafa Kamal, Anwar Mansour Alnakhl. The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism. European journal of clinical pharmacology. 2024-02-29. PMID:38421437. |
the polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among saudi children with autism. |
2024-02-29 |
2024-03-02 |
Not clear |
| Sireen Abdul Rahim Shilbayeh, Iman Sharaf Adeen, Ayman Shawqi Alhazmi, Haya Aljurayb, Rana Saad Altokhais, Nourah Alhowaish, Khawlah Essa Aldilaijan, Mostafa Kamal, Anwar Mansour Alnakhl. The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism. European journal of clinical pharmacology. 2024-02-29. PMID:38421437. |
antipsychotics, including risperidone (ris), are frequently indicated for various autism spectrum disorder (asd) manifestations; however, "actionable" pgx testing in psychiatry regarding antipsychotic dosing and selection has limited applications in routine clinical practice because of the lack of standard guidelines, mostly due to the inconsistency and scarcity of genetic variant data. |
2024-02-29 |
2024-03-02 |
Not clear |
| Sireen Abdul Rahim Shilbayeh, Iman Sharaf Adeen, Ezzeldeen Hasan Ghanem, Haya Aljurayb, Khawlah Essa Aldilaijan, Fatimah AlDosari, Abeer Fadd. Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism. Frontiers in pharmacology. vol 15. 2024-02-20. PMID:38375040. |
exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in saudi children with autism. |
2024-02-20 |
2024-02-22 |
Not clear |
| Asmaa S Mohamed, Hosam M Ahmad, Ahmed A Abdelrahman, Usama F Aly, Khaled A Khale. Therapeutic Impacts of Hyperbaric Oxygen Therapy and Risperidone on Children with Autism: A Clinical Trial. Basic and clinical neuroscience. vol 14. issue 4. 2023-12-05. PMID:38050572. |
therapeutic impacts of hyperbaric oxygen therapy and risperidone on children with autism: a clinical trial. |
2023-12-05 |
2023-12-10 |
Not clear |
| Asmaa S Mohamed, Hosam M Ahmad, Ahmed A Abdelrahman, Usama F Aly, Khaled A Khale. Therapeutic Impacts of Hyperbaric Oxygen Therapy and Risperidone on Children with Autism: A Clinical Trial. Basic and clinical neuroscience. vol 14. issue 4. 2023-12-05. PMID:38050572. |
in this research, we investigated any possible effect of receiving hyperbaric oxygen therapy (hbot) or risperidone on the core symptoms of autism in children diagnosed with autism spectrum disorder (asd). |
2023-12-05 |
2023-12-10 |
Not clear |
| Sireen Abdul Rahim Shilbayeh, Iman Sharaf Adeen, Ayman Shawqi Alhazmi, Samah Fathy Ibrahim, Fawwaz Abdul Razaq Al Enazi, Ezzeldeen Hasan Ghanem, Adel Mohammed Binduraihe. The Frequency of CYP2D6 and CYP3A4/5 Genotypes and The Impact of Their Allele Translation and Phenoconversion-Predicted Enzyme Activity on Risperidone Pharmacokinetics in Saudi Children with Autism. Biochemical genetics. 2023-12-02. PMID:38041757. |
the frequency of cyp2d6 and cyp3a4/5 genotypes and the impact of their allele translation and phenoconversion-predicted enzyme activity on risperidone pharmacokinetics in saudi children with autism. |
2023-12-02 |
2023-12-10 |
Not clear |
| Rebecca A Hermans, Alaya E M Storm, Sanne M Kloosterboer, Manon H J Hillegers, Birgit C P Koch, Bram Dierckx, Brenda C M de Winte. Therapeutic Drug Monitoring to Optimize Risperidone Treatment in Children with Autism Spectrum Disorder. Therapeutic drug monitoring. 2023-11-29. PMID:38019457. |
therapeutic drug monitoring to optimize risperidone treatment in children with autism spectrum disorder. |
2023-11-29 |
2023-12-07 |
Not clear |
| Rebecca A Hermans, Alaya E M Storm, Sanne M Kloosterboer, Manon H J Hillegers, Birgit C P Koch, Bram Dierckx, Brenda C M de Winte. Therapeutic Drug Monitoring to Optimize Risperidone Treatment in Children with Autism Spectrum Disorder. Therapeutic drug monitoring. 2023-11-29. PMID:38019457. |
risperidone is an atypical antipsychotic drug used to treat irritability and aggression in children and adolescents with autism spectrum disorder. |
2023-11-29 |
2023-12-07 |
Not clear |
| Hirla Costa Silva Fukushima, Ricardo Lacava Bailone, Ricardo Carneiro Borr. Assessment of Risperidone Toxicity in Zebrafish ( Comparative medicine. vol 73. issue 4. 2023-10-11. PMID:37536933. |
assessment of risperidone toxicity in zebrafish ( risperidone is an antipsychotic medication used in the treatment of conditions like autism and schizophrenia. |
2023-10-11 |
2023-10-15 |
zebrafish |
| Jhenelle Hutchinson, Oluwa Folawemi, Parikshit Bittla, Simran Kaur, Vani Sojitra, Anam Zahra, Safeera Kha. The Effects of Risperidone on Cognition in People With Autism Spectrum Disorder: A Systematic Review. Cureus. vol 15. issue 9. 2023-09-21. PMID:37731686. |
the effects of risperidone on cognition in people with autism spectrum disorder: a systematic review. |
2023-09-21 |
2023-10-07 |
Not clear |
| Jhenelle Hutchinson, Oluwa Folawemi, Parikshit Bittla, Simran Kaur, Vani Sojitra, Anam Zahra, Safeera Kha. The Effects of Risperidone on Cognition in People With Autism Spectrum Disorder: A Systematic Review. Cureus. vol 15. issue 9. 2023-09-21. PMID:37731686. |
to date, there is no one drug approved to treat the core symptoms of autism spectrum disorder, but antipsychotic drugs such as risperidone have been shown to be effective at treating both core and non-core symptoms in controlled trials using multiple behavioral rating scales such as the aberrant behavioral checklist subscale, the clinical global impression improvement scale, the ritvo-freeman real life scale, the children's yale-brown obsessive compulsive scale, the vineland adaptive behavior scale, and the social withdrawal subscale. |
2023-09-21 |
2023-10-07 |
Not clear |
| Luis Phillipe Nagem Lopes, Alexander Itria, Luciane Cruz Lope. Budget Impact Analysis of Risperidone Use and Adverse Event Monitoring in Autism Spectrum Disorder in Brazil: Assessment of Theoretical Versus Real Data. PharmacoEconomics - open. 2023-09-14. PMID:37707722. |
budget impact analysis of risperidone use and adverse event monitoring in autism spectrum disorder in brazil: assessment of theoretical versus real data. |
2023-09-14 |
2023-10-07 |
Not clear |
| Luis Phillipe Nagem Lopes, Alexander Itria, Luciane Cruz Lope. Budget Impact Analysis of Risperidone Use and Adverse Event Monitoring in Autism Spectrum Disorder in Brazil: Assessment of Theoretical Versus Real Data. PharmacoEconomics - open. 2023-09-14. PMID:37707722. |
risperidone is used in autism spectrum disorder (asd) to manage aggressive behavior. |
2023-09-14 |
2023-10-07 |
Not clear |
| Mehry Nasiri, Zohal Parmoon, Yalda Farahmand, Ali Moradi, Kimia Farahmand, Kamyar Moradi, Fatemeh A Basti, Mohammad-Reza Mohammadi, Shahin Akhondzade. l-carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial. International clinical psychopharmacology. 2023-08-08. PMID:37551601. |
present study was designed to evaluate the efficacy and safety of l-carnitine as an adjuvant agent to risperidone in the treatment of autism spectrum disorder (asd)-associated behaviors. |
2023-08-08 |
2023-08-14 |
Not clear |
| Mohamed Z Habib, Esraa M Elnahas, Yasmin M Aboul-Ela, Mai A Ebeid, Marwa Tarek, Doaa R Sadek, Eman A Negm, Dina A Abdelhakam, Sawsan Aboul-Fotou. Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing. European journal of pharmacology. 2023-07-17. PMID:37460052. |
risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: role of adar2 in ampa glua2 rna editing. |
2023-07-17 |
2023-08-14 |
rat |